Association between the EHBP1 SNPs and dyslipidemia in the end-stage renal disease patients with dialysis in Chinese Han population
- PMID: 39731114
- PMCID: PMC11681726
- DOI: 10.1186/s12944-024-02407-3
Association between the EHBP1 SNPs and dyslipidemia in the end-stage renal disease patients with dialysis in Chinese Han population
Abstract
Background: Lipid metabolism is influenced by mutations in the EH domain binding protein 1 gene (EHBP1). This study investigated the link between the EHBP1 single-nucleotide polymorphisms (SNPs) and dyslipidemia risks in maintenance dialysis patients with end-stage renal disease in Chinese Han population.
Methods: A total of 539 patients were divided into dyslipidemia (379) and control (160) groups. The patients with dyslipidemia were divided into four subgroups: high low-density lipoprotein cholesterol, low high-density lipoprotein cholesterol (HDLC), high triglyceride (TG) and high total cholesterol groups. The genotype distributions of three EHBP1 SNPs (rs2710642, rs10496099 and rs1168816) were determined by high-throughput sequencing technology and were analyzed via generalized multifactor dimension reduction and binary logistic regression analysis.
Results: The high-TG and control groups differed in terms of the genotype frequency of the rs2710642. One haplotype was detected in both the dyslipidemia and high-TG groups. The risk of dyslipidemia was 2.72-fold higher in participants with rs2710642GG compared with those of rs2710642AA and 2.62-fold higher compared with those with rs2710642AA + GA. Subjects who carried rs2710642GG had a 2.94 times greater risk of high TG levels than those who carried rs2710642AA and a 2.89 times greater risk than those who carried rs2710642AA + GA. Compared with those who carried rs2710642AA + GA, those who carried rs2710642GG were 2.53 times more likely to have low HDLC levels. The rs2710642-body mass index (BMI) (≥ 24 kg/m2) and rs11688816A-rs2710642G haplotype interactions increased the risk of dyslipidemia, and the rs2710642-BMI (≥ 24 kg/m2) interaction increased the risk of high TG levels. The rs10496099-rs2710642 and rs10496099-rs2710642-rs11688816 interactions increased the risk of low HDLC levels.
Conclusions: These results suggest that the EHBP1 rs2710642G and rs2710642GG and interactions with rs11688816A or BMI (≥ 24 kg/m2) were linked to higher dyslipidemia risks in end-stage renal disease patients in Chinese Han population.
Keywords: EHBP1; Dyslipidemia; End-stage renal disease; Single nucleotide polymorphism.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of the Fourth Affiliated Hospital of Guangxi Medical University (No. KY2021002). All participants provided written informed consent for the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures


Similar articles
-
EHBP1 SNPs, Their Haplotypes, and Gene-Environment Interactive Effects on Serum Lipid Levels.ACS Omega. 2020 Mar 27;5(13):7158-7169. doi: 10.1021/acsomega.9b03522. eCollection 2020 Apr 7. ACS Omega. 2020. PMID: 32280856 Free PMC article.
-
EHBP1, TUBB, and WWOX SNPs, Gene-Gene and Gene-Environment Interactions on Coronary Artery Disease and Ischemic Stroke.Front Genet. 2022 Apr 26;13:843661. doi: 10.3389/fgene.2022.843661. eCollection 2022. Front Genet. 2022. PMID: 35559044 Free PMC article.
-
LIPG SNPs, their haplotypes and gene-environment interactions on serum lipid levels.Lipids Health Dis. 2019 Jan 8;18(1):10. doi: 10.1186/s12944-018-0942-y. Lipids Health Dis. 2019. PMID: 30621702 Free PMC article. Clinical Trial.
-
[The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Apr;22(2):151-7. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005. PMID: 15793775 Chinese.
-
Association of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population.Lipids Health Dis. 2015 Oct 9;14:124. doi: 10.1186/s12944-015-0126-y. Lipids Health Dis. 2015. PMID: 26449542 Free PMC article.
Cited by
-
Mendelian randomization analysis reveals potential causal relationships between serum lipid metabolites and prostate cancer risk.Discov Oncol. 2025 Apr 24;16(1):602. doi: 10.1007/s12672-025-02388-4. Discov Oncol. 2025. PMID: 40272633 Free PMC article.
References
-
- Dusejovska M, Vecka M, Rychlik I, Zak A. Dyslipidemia in patients with chronic kidney disease: etiology and management. Vnitr Lek. 2020;66(5):275–81. - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
- No. Z-B20221470/the Self-funded Scientific Research Project of Guangxi Zhuang Autonomous Region Health Commission
- grant number 2023GXNSFAA026050/the Natural Science Foundation of Guangxi Zhuang Autonomous Region
- 2024GXNSFAA010049/the Natural Science Foundation of Guangxi Zhuang Autonomous Region
- No. 2021CBC0119/the Science and Technology Planning project in Liuzhou City
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous